Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Assets (2016 - 2025)

Historic Assets for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $49.5 million.

  • Jaguar Health's Assets fell 1538.33% to $49.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $202.6 million, marking a year-over-year decrease of 1037.35%. This contributed to the annual value of $53.4 million for FY2024, which is 524.4% up from last year.
  • Jaguar Health's Assets amounted to $49.5 million in Q3 2025, which was down 1538.33% from $48.3 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Assets registered a high of $69.5 million during Q2 2021, and its lowest value of $45.4 million during Q3 2023.
  • For the 5-year period, Jaguar Health's Assets averaged around $54.5 million, with its median value being $52.9 million (2022).
  • In the last 5 years, Jaguar Health's Assets soared by 10649.42% in 2021 and then tumbled by 2826.33% in 2022.
  • Jaguar Health's Assets (Quarter) stood at $53.3 million in 2021, then fell by 10.91% to $47.5 million in 2022, then rose by 6.98% to $50.8 million in 2023, then grew by 5.24% to $53.4 million in 2024, then decreased by 7.4% to $49.5 million in 2025.
  • Its Assets stands at $49.5 million for Q3 2025, versus $48.3 million for Q2 2025 and $51.5 million for Q1 2025.